| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |